SCHEMBL7315482

SCHEMBL7315482

N#Cc1cccc(COc2ccc3c(c2)c(CCN)cn3Cc2ccc(Br)cc2C(=O)O)c1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.44
FFAR4 Q5NUL3 1/20 0.44
EGFR P00533 4/20 0.43
IGF1R P08069 4/20 0.43
FLT4 P35916 4/20 0.43
KDR P35968 4/20 0.43
LTB4R Q15722 3/20 0.42
LTB4R2 Q9NPC1 3/20 0.42
ALKBH1 Q13686 1/20 0.42
MAOB P27338 3/20 0.41
MAOA P21397 2/20 0.41
PPARG P37231 2/20 0.41
PPARD Q03181 2/20 0.41
PPARA Q07869 2/20 0.41
CYSLTR2 Q9NS75 1/20 0.39
CYSLTR1 Q9Y271 1/20 0.39
MRGPRX4 Q96LA9 1/20 0.39
PDCD1 Q15116 3/20 0.39
CD274 Q9NZQ7 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7317280 0.85 PTGER1 (0.43) EGFRIGF1RFLT4KDRLTB4R
SCHEMBL7318738 0.85 ALKBH1 (0.49) FFAR1FFAR4EGFRIGF1RFLT4
SCHEMBL7320717 0.83 EGFR (0.50) FFAR1FFAR4EGFRIGF1RFLT4
SCHEMBL7319193 0.83 FFAR1 (0.47) FFAR1FFAR4EGFRIGF1RFLT4
SCHEMBL7319754 0.82 TP53 (0.47) EGFRIGF1RFLT4KDRLTB4R
SCHEMBL7313126 0.82 EGFR (0.46) FFAR1FFAR4EGFRIGF1RFLT4
SCHEMBL7307437 0.81 ALKBH1 (0.49) FFAR1FFAR4EGFRIGF1RFLT4
SCHEMBL7319275 0.79 EGFR (0.49) FFAR1FFAR4EGFRIGF1RFLT4
Trifluoroacetic Acid SCHEMBL7316960 0.79 EGFR (0.50) FFAR1FFAR4EGFRIGF1RFLT4
Trifluoroacetic Acid SCHEMBL7315177 0.79 EGFR (0.54) FFAR1FFAR4EGFRIGF1RFLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010007877-A1 NOVEL ANTI-INFECTIVES SMITHKLINE BEECHAM CORPORATION 2001-07-12 US claimed
WO-2001034146-A1 NOVEL ANTI-INFECTIVES SMITHKLINE BEECHAM CORPORATION (US) 2001-05-17 WO claimed
US-20010007877-A1 NOVEL ANTI-INFECTIVES SMITHKLINE BEECHAM CORPORATION 2001-07-12 US disclosed
WO-2001034146-A1 NOVEL ANTI-INFECTIVES SMITHKLINE BEECHAM CORPORATION (US) 2001-05-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010007877-A1 NOVEL ANTI-INFECTIVES CTSL, MMP8, SERPINB1 FFAR1 4207/4885FFAR4 4268/4885EGFR 4683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.